Stay updated on Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page
- Check5 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1 while the study page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-denied message. The prior study details and related navigation are no longer visible on this page.SummaryDifference17%

- Check26 days agoChange DetectedA new page revision identifier 'Revision: v3.7.0' has been added. The previous revision 'Revision: v3.6.6' has been removed, reflecting an update to the page's versioning.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page's Revision value changed from v3.6.5 to v3.6.6. This indicates a minor update to the page without altering the displayed study details.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.4 to Revision: v3.6.5. This indicates a small internal update to the page software and does not modify study details or public-facing content.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page shows a new revision tag (v3.6.4) replacing the previous v3.6.3, reflecting a software deployment/update to the page rendering.SummaryDifference0.1%

Stay in the know with updates to Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.